In silico solutions for biopharma R&D

Powered by generative AI, computational biology, computational chemistry & cloud.

From data to targets & biomarkers, therapeutics, CMC and trials

Target and Biomarker Research

De-risking & accelerating drug discovery with precision target and biomarker identification, assessment & validation

Read More

Small Molecule Engineering

(Upper) Chemical structures of small-molecule drugs (SMOLs), i.e. naltrexone, methotrexate, and doxorubicin. (Lower) Space-filling models of the SMDs: carbon (dark grey), hydrogen (light grey), nitrogen (blue), oxygen (red).

AI-powered drug discovery platform for faster and cost-effective de novo small molecule design, characterization, optimization, and synthesis.

Read More

Antibody Engineering

Structure of a populat TNF-alpha blocker showing light chain, heavy chain, and lipophilicity

Accelerating antibody engineering with gen AI in silico solutions

Read More

RNA Therapies

Rather than provide a vaccine made from viral proteins, this COVID-19 vaccine is composed of synthetic viral mRNA. These molecules are injected into people and cellular protein-making machines, called ribosomes, read and translate the mRNA. It’s these proteins that then trigger an immune response.

Solutions for mRNA, ASO, and LNP design & optimization 

Read More

Gene Therapies

Vector design, optimization, safety, and synthesis solutions with Gen AI and LRS

Read More

Enzyme Engineering

Enzyme engineering strategies

Gen AI powered in silico enzyme characterization and optimization

Read More

Process R&D

Suzuki Coupling Full Mechanism showing Reductive Elimination, Oxidative Addition, and Transmetalation

Machine learning-powered computational chemistry methods to predict reaction yields

Read More

Discover our offerings across the biopharma value chain

Learn more about our platform, solutions, and services